SYM vs UTHR · rev $2.25B vs P/E 20, rev $2.88B
Symbotic Inc (SYM) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Symbotic Inc (SYM) is a specialty industrial machinery company listed on NASDAQ.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported SYM revenue for 2025-09-27 was $2.25B. Net income was -$91.0M. Revenue was up 298.0% from 2024-09-28 to 2025-09-27. SYM currently screens at market cap $24.25B.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
SYM currently screens at market cap $24.25B. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the SYM and UTHR stock pages for the full models.
Not investment advice.